Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Nov;200(5):655-8.
doi: 10.1016/j.amjsurg.2010.08.001.

Multilayered microcapsules for the sustained-release of angiogenic proteins from encapsulated cells

Affiliations
Comparative Study

Multilayered microcapsules for the sustained-release of angiogenic proteins from encapsulated cells

Omaditya Khanna et al. Am J Surg. 2010 Nov.

Abstract

Background: Multilayered alginate microcapsules with a permselective poly-L-ornithine membrane can be used for the dual purpose of encapsulating cells in the inner core and sustained release of angiogenic proteins from the outer layer. The aim of this study was to examine the encapsulation and release of a novel chimeric form of fibroblast growth factor-1 (FGF-1) from the outer layer of alginate microcapsules.

Methods: Heparin-binding growth-associated molecule bound to FGF-1 (HB-GAM/FGF-1) was encapsulated in the outer layer of multilayered alginate microbeads constructed using varying alginate conditions. The encapsulation and release of the chimera was quantified.

Results: The outer layer was able to encapsulate and release HB-GAM/FGF-1 for up to 30 days. The outer layer made with 1% alginate of high mannuronic acid content provided the fastest release, while 1.25% high guluronic acid content alginate displayed the longest duration of release.

Conclusions: The outer layer of multilayered alginate microbeads can be used for the encapsulation and long-term release of HB-GAM/FGF-1.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A visual schematic of the concept behind multilayered alginate microbeads. Islets are encapsulated in the inner core, and an angiogenic protein (HB-GAM/FGF-1) in the outer alginate layer. The permselective PLO membrane prevents the diffusion of large molecules such as antibodies, but allows for the exchange of solutes such as glucose, oxygen and insulin. When implanted the protein is released from the outer layer and stimulates neovascaularization towards the bead.
Figure 2
Figure 2
The realease of HB-GAM/FGF-1 from the outer layer of multilayered alginate microbeads varied based on the composition and concentration of alginate used. An initial burst release of HB-GAM/FGF-1 is exhibited for all four groups studied (A), and release at low-levels is continued for up to thirty days (B).
Figure 3
Figure 3
A comparison of the release profiles of FGF-1 with heparin and HB-GAM/FGF-1 encapsulated in alginate microbeads with a 1.25% LVG outer layer. HB-GAM/FGF-1 has a much higher initial burst release than FGF-1, but its continued long-term release that would serve to achieve persistent neovascularization.

Similar articles

Cited by

References

    1. Miao G, Mace J, Kirby M, Hopper A, Peverini R, Chinnock R, et al. Beneficial effects of nerve growth factor on islet transplantation. Transplant Proc. 2005 Oct;37(8):3490–2. - PubMed
    1. Kizilel S, Garfinkel M, Opara E. The bioartificial pancreas: progress and challenges. Diabetes Technol Ther. 2005 Dec;7(6):968–85. - PubMed
    1. Augst AD, Kong HJ, Mooney DJ. Alginate hydrogels as biomaterials. Macromol Biosci. 2006 Aug 7;6(8):623–33. - PubMed
    1. Moya ML, Garfinkel MR, Liu X, Lucas S, Opara EC, Greisler HP, et al. Fibroblast Growth Factor-1 (FGF-1) Loaded Microbeads Enhance Local Capillary Neovascularization. J Surg Res. 2010;160:208–212. - PMC - PubMed
    1. Garfinkel MR, Harland RC, Opara EC. Optimization of the microencapsulated islet for transplantation. J Surg Res. 1998 Apr;76(1):7–10. - PubMed

Publication types

MeSH terms